CORONA Remedies Limited: CARE Ratings Reaffirms 'CARE A+; Stable' on Bank Facilities
CORONA Remedies Limited's bank facilities have been reaffirmed with a 'CARE A+; Stable' rating by CARE Rating Limited. This includes ₹25.00 crore in long-term facilities and ₹70.00 crore in long-term/short-term facilities. The reaffirmation is based on the company's performance in FY25 and H1FY26.
A reaffirmed credit rating is important for a company's borrowing capacity and cost of capital, indicating continued financial stability and risk assessment by a rating agency.
The credit rating has been reaffirmed, which is a neutral event as it indicates stability rather than a significant positive or negative change.
CORONA Remedies Limited has announced that CARE Rating Limited has reaffirmed its credit ratings on the company's bank facilities. The rating for Long-Term Bank Facilities of ₹25.00 crore (reduced from ₹73.00 crore) has been reaffirmed as CARE A+; Stable. Additionally, the ratings for Long-Term / Short-Term Bank Facilities totaling ₹70.00 crore have also been reaffirmed as CARE A+; Stable / CARE A1.
These ratings are based on the company's operational and financial performance for FY25 (Audited) and H1FY26 (Unaudited). The total rated facilities amount to ₹95.00 crore, comprising ₹25.00 crore in Long-Term Facilities and ₹70.00 crore in Long-Term / Short-Term Facilities. The detailed breakdown includes ₹25.00 crore in Term Loans from Citi Bank and ₹70.00 crore in Fund Based / Non-Fund Based Limits from ICICI Bank Ltd. and Citi Bank.
What to do with a filing like this
CORONA Remedies Limited filed this with the NSE as a statutory disclosure, categorised under credit ratings. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by CORONA Remedies Limited. Read the original for the full detail.